CrushSCI.com
138Average days
123Median days
75Fastest days
219Longest days
192025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

219 days

A multiplex immunostaining method for characterization of immune cells in non-human primate ocular tissue sections with intraocular inflammation

Authors
Rong Nie; Christina Preece; Joshua Rowe; Swati Gupta; Lydia Andrews-Jones; Margaret RamosShow moreShow less
Affiliations
1. Abbvie Development Biological Sciences, Local Delivery and Translational Sciences; 2. Abbvie Preclinical Safety, PathologyShow moreShow less
Source PDF DOI Publisher page
198 days

An integrated protocol for multiplexed DNA FISH and protein detection in large tissue sections

Authors
Eleanor M. O´Roberts; Pranauti Panshikar; Xiaoze Li Wang; Christophe Avenel; Quentin Verron; Eléna Coulier; Magda Bienko; Charlotte StadlerShow moreShow less
Affiliations
1. Royal Institute of Technology; 2. Science for Life Laboratory; 3. Karolinska Institutet; 4. Uppsala University; 5. Human Technopole; 6. Theme Cancer, KarolinskaShow moreShow less
Source PDF DOI Publisher page
123 days

Optimisation of Xenium automated in situ sequencing for PAXgene-fixed tissue samples

Authors
Kenny Roberts; Andrew R. BassettShow moreShow less
Affiliations
1. Wellcome Genome CampusShow moreShow less
Source PDF DOI Publisher page
75 days

Unraveling myoepithelial cell plasticity in breast cancer: a transcriptomic approach

Authors
Mohamed M. Haq; Curtis Benson; Meik Kunz; Elim Y.L. CheungShow moreShow less
Affiliations
1. HCA Houston Healthcare Southeast; 2. The Bioinformatics CRO; 3. BioChain InstituteShow moreShow less
Source PDF DOI Publisher page
75 days

TissuStamp: a novel high-throughput tissue transfer workflow for FFPE spatial biology assays

Authors
Albert Velasco Abadia; Gina Benedetto; Zhenmin Hong; Jaekyung Koh; Sarthak Duggal; Sandor Kovacs; Mohammad Vatankhah Varnosfaderani; Mark Kalaj; Bandele Jeffrey-Coker; Anthony Facchini; McKenzie Pavlich; Wijendra Jude Senarathne; Digvijay Singh; Patricia Aurelina; Michael Lawson; Sabrina Shore; Kevin Marshall; Yuji Ishitsuka; Eli Glezer; Daan WittersShow moreShow less
Affiliations
1. Singular Genomics SystemsShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF HISTOTECHNOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 5 complete review records for JOURNAL OF HISTOTECHNOLOGY. The fastest paper went from submission to acceptance in 75 days (Unraveling myoepithelial cell plasticity in breast cancer: a transcriptomic approach, received 2026-01-06, accepted 2026-03-22); the slowest took 219 days. The average is 138 days and the median is 123 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.